B2Bioworld - Awassa Hospital Ethiopia Roche Ethiopia: Build-up of an emerging market

January 2012. Fondation Roche Afrique finances a project in Ethiopia which will impact health care in the region. A change in Roche's access to medicines programmes. In a move to strengthen its foothold in East Africa, the Swiss pharma and diagnostics company is accelerating a cancer care program to offer patients access to its products, educate health professionals, and recruit patients. A report by Bikila Wolde on Roche's plans and prospects.

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 2 pages
- Includes details on Tikur Anbessa Hospital (General/Cancer Care (Patients, Beds, Specialist Physicians, etc.)

Full Company License enquire here

Back to section

Related Editorial Articles

Pharma Boost for Red Cross/Red Crescent
- Community Disease Prevention Programme

The Global Dimension of EU Health and Food Policies
Paola Testori-Coggi, at the time Director-General for Health and Consumers, European Commission

FAO: Major shifts expected in operations

No Mercy with Violators of Corporate Compliance
Rüdiger Scheitza, former Member of the Board Bayer CropScience, and Labour Director (until June 2013) on ensuring governance and compliance around the world - developing countries included

WHO ECEH taps major donation and streamlines European operations

Adhering to Values Pays Off
Novartis continues to expand the biotech therapeutics pipeline / Focus on emerging markets

Stem Cells: a discovery tool and a potential therapeutic modality
Jonathan Knowles, past Member of the Roche Executive Committee and Head of Group Research Leveraging different methods and technologies – clarifying the concept of personalised medicine